FDA.reportPublic FDA data

bexagliflozin 20 MG Oral Tablet [Brenzavvy]

RxCUI
2637865
RxNorm name
bexagliflozin 20 MG Oral Tablet [Brenzavvy]
Display name
bexagliflozin 20 MG Oral Tablet [Brenzavvy]
Full name
bexagliflozin 20 MG Oral Tablet [Brenzavvy]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRENZAVVYBEXAGLIFLOZINTheracosBio, LLC3cdf28fc-4194-4ad6-aa03-c9eaa68da83e2026-06-10Warnings, Adverse reactionsExact identifier
rxcui: 2637865

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3cdf28fc-4194-4ad6-aa03-c9eaa68da83eBrenzavvy 20 MG Oral Tablet [PSN] · bexagliflozin 20 MG Oral Tablet [Brenzavvy] [SBD] · Brenzavvy 20 MG Oral Tablet [SY]38These highlights do not include all the information needed to use BRENZAVVY safely and effectively. See full prescribing information for BRENZAVVY. BRENZAVVY (bexagliflozin) tablets, for oral use Initial U.S. Approval: 202320251111